165 related articles for article (PubMed ID: 20229037)
1. Response to oxidative stress in eight pathogenic yeast species of the genus Candida.
Abegg MA; Alabarse PV; Casanova A; Hoscheid J; Salomon TB; Hackenhaar FS; Medeiros TM; Benfato MS
Mycopathologia; 2010 Jul; 170(1):11-20. PubMed ID: 20229037
[TBL] [Abstract][Full Text] [Related]
2. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
3. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
4. Bacterial lipopolysaccharides variably modulate in vitro biofilm formation of Candida species.
Bandara HMHN; Lam OLT; Watt RM; Jin LJ; Samaranayake LP
J Med Microbiol; 2010 Oct; 59(Pt 10):1225-1234. PubMed ID: 20576747
[TBL] [Abstract][Full Text] [Related]
5. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
6. Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida.
Hospenthal DR; Beckius ML; Floyd KL; Horvath LL; Murray CK
Ann Clin Microbiol Antimicrob; 2006 Jan; 5():1. PubMed ID: 16390552
[TBL] [Abstract][Full Text] [Related]
7. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis.
Yang YL; Ho YA; Cheng HH; Ho M; Lo HJ
Infect Control Hosp Epidemiol; 2004 Jan; 25(1):60-4. PubMed ID: 14756222
[TBL] [Abstract][Full Text] [Related]
8. Differential response of Candida albicans and Candida glabrata to oxidative and nitrosative stresses.
Cuéllar-Cruz M; López-Romero E; Ruiz-Baca E; Zazueta-Sandoval R
Curr Microbiol; 2014 Nov; 69(5):733-9. PubMed ID: 25002360
[TBL] [Abstract][Full Text] [Related]
9. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.
Quindós G; Ruesga MT; Martín-Mazuelos E; Salesa R; Alonso-Vargas R; Carrillo-Muñoz AJ; Brena S; San Millán R; Pontón J
Rev Iberoam Micol; 2004 Jun; 21(2):63-9. PubMed ID: 15538829
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress response involving induction of protective enzymes in Candida dubliniensis.
Tosello ME; Biasoli MS; Luque AG; Magaró HM; Krapp AR
Med Mycol; 2007 Sep; 45(6):535-40. PubMed ID: 17710623
[TBL] [Abstract][Full Text] [Related]
11. Isolation of Candida dubliniensis in denture stomatitis.
Marcos-Arias C; Vicente JL; Sahand IH; Eguia A; De-Juan A; Madariaga L; Aguirre JM; Eraso E; Quindós G
Arch Oral Biol; 2009 Feb; 54(2):127-31. PubMed ID: 18950745
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N
Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
[TBL] [Abstract][Full Text] [Related]
13. In vitro antifungal effect of amine fluoride-stannous fluoride combination on oral Candida species.
Meurman JH; Kari K; Waltimo T; Kotiranta A; Inkeri J; Samaranayake LP
Oral Dis; 2006 Jan; 12(1):45-50. PubMed ID: 16390468
[TBL] [Abstract][Full Text] [Related]
14. Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.
Posteraro B; Spanu T; Fiori B; De Maio F; De Carolis E; Giaquinto A; Prete V; De Angelis G; Torelli R; D'Inzeo T; Vella A; De Luca A; Tumbarello M; Ricciardi W; Sanguinetti M
Antimicrob Agents Chemother; 2015 Jul; 59(7):3944-55. PubMed ID: 25896705
[TBL] [Abstract][Full Text] [Related]
15. Patterns of amphotericin B killing kinetics against seven Candida species.
Cantón E; Pemán J; Gobernado M; Viudes A; Espinel-Ingroff A
Antimicrob Agents Chemother; 2004 Jul; 48(7):2477-82. PubMed ID: 15215097
[TBL] [Abstract][Full Text] [Related]
16. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
[TBL] [Abstract][Full Text] [Related]
17. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
[TBL] [Abstract][Full Text] [Related]
18. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)].
Durán MT; Velasco D; Canle D; Moure R; Villanueva R
Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin.
García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256
[TBL] [Abstract][Full Text] [Related]
20. Candida infection in the intensive care unit: A study of antifungal susceptibility pattern of Candida species in Milad hospital, Tehran, Iran.
Alimehr S; Shekari Ebrahim Abad H; Fallah F; Rahbar M; Mohammadzadeh M; Vossoghian S; Rafeei Tabatabaee S; Roudbary M; Zaini F
J Mycol Med; 2015 Dec; 25(4):e113-7. PubMed ID: 26563641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
